SCHEMBL7511960

SCHEMBL7511960

[CH2]COCOc1cc(C)c(Br)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
TSHR P16473 2/20 0.39
MAPT P10636 6/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PRKDC P78527 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
POLB P06746 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
NQO2 P16083 1/20 0.33
NPC1 O15118 1/20 0.33
CYP2C9 P11712 1/20 0.33
RAB9A P51151 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5250489 0.79 L3MBTL1 (0.40) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL1505362 0.78 MAPT (0.52) L3MBTL1SMN1; SMN2TSHRMAPTNPSR1
SCHEMBL21823607 0.78 LMNA (0.49) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL31096332 0.78 LMNA (0.49) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL19828675 0.75 KDM4E (0.44) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL17529471 0.73 PDE3B (0.47) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL3370500 0.73 L3MBTL1 (0.48) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL17864752 0.73 PDE3B (0.47) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL19814072 0.72 MAOB (0.42) L3MBTL1SMN1; SMN2TSHRMAPTLMNA
SCHEMBL20562352 0.70 MEN1 (0.54) L3MBTL1SMN1; SMN2MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218348-A2 INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEIN KINASES, AND METHODS FOR THEIR USE AGOURON PHARMACEUTICALS, INC. (US) 2002-07-03 EP disclosed
WO-2001002369-A2 INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEIN KINASES, AND METHODS FOR THEIR USE AGOURON PHARMACEUTICALS, INC. (US) 2001-01-11 WO disclosed